Afdhal Nezam H, Nunes David
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02125, USA.
Am J Gastroenterol. 2004 Jun;99(6):1160-74. doi: 10.1111/j.1572-0241.2004.30110.x.
The diagnosis of liver fibrosis has traditionally relied on liver biopsy. However, recent studies have suggested that there can be up to a 33 % error in the diagnosis of cirrhosis. In this article, we review the current status of liver biopsy as a gold standard for the diagnosis of liver fibrosis and discuss the radiological and serum tests that have been proposed as potential adjuncts or alternatives to biopsies. Indirect markers of liver fibrosis which reflect alterations in liver function and or inflammation are discussed as well as more direct markers of liver fibrosis. The limitations of utilization of these markers for both cross-sectional diagnosis of fibrosis and monitoring disease progression or regression are discussed.
传统上,肝纤维化的诊断依赖于肝活检。然而,最近的研究表明,肝硬化的诊断可能存在高达33%的误差。在本文中,我们回顾了肝活检作为肝纤维化诊断金标准的现状,并讨论了已被提议作为活检潜在辅助手段或替代方法的放射学和血清学检查。我们还讨论了反映肝功能和/或炎症改变的肝纤维化间接标志物以及更直接的肝纤维化标志物。同时也讨论了这些标志物在纤维化横断面诊断以及监测疾病进展或逆转方面应用的局限性。